1.5149
0.32%
0.0049
전일 마감가:
$1.51
열려 있는:
$1.53
하루 거래량:
37,639
Relative Volume:
0.11
시가총액:
$77.79M
수익:
-
순이익/손실:
$-68.96M
주가수익비율:
-0.9294
EPS:
-1.63
순현금흐름:
$-56.62M
1주 성능:
-0.34%
1개월 성능:
-5.91%
6개월 성능:
-13.93%
1년 성능:
-77.42%
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
명칭
Pmv Pharmaceuticals Inc
전화
(609) 642-6664
주소
ONE RESEARCH WAY, PRINCETON
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2022-03-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
2021-09-22 | 업그레이드 | Goldman | Neutral → Buy |
2021-08-19 | 개시 | Oppenheimer | Perform |
2021-08-02 | 개시 | Guggenheim | Buy |
2021-07-29 | 개시 | H.C. Wainwright | Buy |
2020-10-20 | 개시 | BofA Securities | Buy |
2020-10-20 | 개시 | Cowen | Outperform |
2020-10-20 | 개시 | Evercore ISI | Outperform |
2020-10-20 | 개시 | Goldman | Neutral |
모두보기
Pmv Pharmaceuticals Inc 주식(PMVP)의 최신 뉴스
PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com Canada
PMV Pharmaceuticals CFO sells over $4,300 in company stock By Investing.com - Investing.com Canada
PMV Pharmaceuticals executive sells over $10k in company stock - Investing.com India
PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com Australia
Insider Selling: PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Insider Sells 7,218 Shares of Stock - MarketBeat
PMV Pharmaceuticals CFO sells over $4,300 in company stock - Investing.com India
PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com UK
Closing Figures: PMV Pharmaceuticals Inc (PMVP)’s Negative Finish at 1.58, Down -1.25 - The Dwinnex
Assenagon Asset Management S.A. Has $401,000 Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Envestnet Portfolio Solutions Inc. Buys 5,351 Shares of MBIA Inc. (NYSE:MBI) - Defense World
Assenagon Asset Management S.A. Boosts Stake in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat
PMV Pharmaceuticals, Inc. to Post Q3 2024 Earnings of ($0.35) Per Share, HC Wainwright Forecasts (NASDAQ:PMVP) - MarketBeat
PMV Pharmaceuticals' (PMVP) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow
Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung - StockTitan
Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung - GlobeNewswire
PMVP (PMV Pharmaceuticals) EPS (Basic) : $-0.97 (TTM As of Jun. 2024) - GuruFocus.com
PMVP (PMV Pharmaceuticals) Purchase Of Investment : $-162.36 Mil (TTM As of Jun. 2024) - GuruFocus.com
PMVP (PMV Pharmaceuticals) GF Value Rank : 0 (As of Aug. 19, 2024) - GuruFocus.com
PMVP (PMV Pharmaceuticals) EV-to-Revenue : (As of Aug. 19, 2024) - GuruFocus.com
Vanguard Group Inc. Purchases 46,804 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
Wharton San Diego Presents: The Future of Biotechnology in San Diego - Procopio
Panasonic (OTCMKTS:PCRFY) Stock Price Crosses Below Fifty Day Moving Average of $9.36 - Defense World
PMV Pharmaceuticals Initiates Strategic Lease Termination - TipRanks
PMV Pharmaceuticals Reports Second Quarter 2024 Financial - GlobeNewswire
PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial - StockTitan
Public Employees Retirement System of Ohio Raises Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans? - Simply Wall St
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Bought by Jacobs Levy Equity Management Inc. - MarketBeat
IMNN-01 Plus Perioperative Chemo Improves OS in Newly Diagnosed, Advanced Ovarian Cancer - OncLive
Acadian Asset Management LLC Increases Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Purchased by Acadian Asset Management LLC - MarketBeat
Mirae Asset Global Investments Co. Ltd. Acquires Shares of 15,492 PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
BNP Paribas Financial Markets Has $597,000 Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World
Mirae Asset Global Investments Co. Ltd. Buys New Stake in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Rezatapopt Takes Aim at Previously Untargetable p53 Allele to Treat Advanced Solid Tumors - OncLive
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 0.6% - Defense World
PMV Pharmaceuticals (NASDAQ:PMVP) Shares Down 0.6% - MarketBeat
PMV Pharmaceuticals Inc (PMVP)’s stock chart: A technical perspective - US Post News
A look into PMV Pharmaceuticals Inc (PMVP)’s deeper side - SETE News
FDA Approves Tepylute for Breast and Ovarian Cancer Treatment - OncLive
Biopharma Layoff Tracker 2024: Ginkgo, Cara, Barinthus and More Cut Staff - BioSpace
PMV Pharmaceuticals Inc Inc. (PMVP) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
PMV Pharmaceuticals Inc (PMVP) shows promising results - US Post News
Views of Wall Street's Leading Experts on PMV Pharmaceuticals Inc – Sete News - SETE News
Quarterly Snapshot: Quick and Current Ratios for PMV Pharmaceuticals Inc (PMVP) – DWinneX - The Dwinnex
PMV Pharmaceuticals Inc (PMVP) presents a great opportunity, but the stock is slightly overvalued – US Post News - US Post News
AFT Pharmaceuticals Limited (AFP) to Issue Final Dividend of $0.01 on July 3rd - Defense World
Here's Why PMV Pharmaceuticals (PMVP) Could be Great Choice for a Bottom Fisher - Yahoo News Malaysia
PMV Pharmaceuticals Inc (PMVP) may enjoy gains as insiders got busy in the recent days – Knox Daily - Knox Daily
Here's Why You Should Consider Buying Bioventus (BVS) Stock - Yahoo Canada Finance
Pmv Pharmaceuticals Inc (PMVP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Pmv Pharmaceuticals Inc 주식 (PMVP) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Carulli Michael | Chief Financial Officer |
Sep 11 '24 |
Sale |
1.50 |
2,891 |
4,347 |
88,395 |
ORBIMED ADVISORS LLC | 10% Owner |
Nov 22 '23 |
Sale |
2.23 |
87,786 |
195,763 |
0 |
Mack David Henry | President and CEO |
Oct 18 '23 |
Option Exercise |
0.53 |
198,407 |
105,156 |
363,877 |
자본화:
|
볼륨(24시간):